 |
| Helicobacter Pylori Infection |
Last updated: Nov 05, 2009 |
 |
|
 |
| |
Helicobacter Pylori Infection |
|
 |
|
 |
Conditions that suggest it | Contributing risk factors | Other conditions that may be present | It can lead to... | Recommendations
 |
|
 |
| |
In recent years, Helicobacter pylori (H. pylori) has been identified by researchers as the cause of the majority of gastrointestinal ulcers. H. pylori is a bacterium that lives in the stomach and duodenum. It has a unique way of adapting to the usually harsh environment of the stomach.
Gastric juice is composed of digestive enzymes and concentrated hydrochloric acid, which can readily digest food or kill microorganisms. Low levels of stomach acid increase the chance an organism's survival. It used to be thought that the stomach contained no bacteria and was actually sterile.
The stomach is protected from its own gastric juice by a thick layer of mucus that covers the stomach lining. H. pylori takes advantage of this protection by living in the mucus lining.
Once H. pylori is safe in the mucus, it is able to fight the stomach acid that does reach it with an enzyme it possesses called urease. Urease converts urea, of which there is an abundant supply in the stomach (from saliva and gastric juices), into bicarbonate and ammonia, which are strong bases. This creates a cloud of acid-neutralizing chemicals around the H. pylori, protecting it from the acid in the stomach. The breath test method of diagnosis relies on this reaction being present.
Contributing to the protection of H. pylori is the fact that the body's natural defenses cannot reach the bacterium in the mucus lining of the stomach. The immune system will respond to an H. pylori infection by sending white cells, killer T cells, and other infection fighting agents. However, these potential H. pylori eradicators cannot reach the infection, because they cannot easily get through the stomach lining. They do not, however, go away - the immune response just grows and grows. White cells die and spill their destructive compounds (superoxide radicals) on stomach lining cells. Extra nutrients are sent to reinforce the white cells, and the H. pylori can feed on this. Within a few days, gastritis and perhaps eventually a peptic ulcer results. It may not be H. pylori itself which causes peptic ulcer, but the body's response (inflammation of the stomach lining).
H. pylori is believed to be transmitted orally. Many researchers believe that H, pylori is transmitted orally by means of fecal matter through the ingestion of waste-tainted food or water. In addition, it is possible that H. pylori could be transmitted from the stomach to the mouth through gastro-esophageal reflux or belching, common symptoms of gastritis. The bacterium could then be transmitted through oral contact.
A 2002 trial demonstrated that a mixed probiotic acidophilus preparation failed to eradicate the H. pylori infection in the patients upon whom it was tried. [Digestion 2002;65(1):pp.16-20]
|
|
 |
|
 |
Conditions that suggest Helicobacter Pylori Infection: | |  | | | | Autoimmune | Crohn's Disease | Drug therapies used to fight the ulcer-causing bacteria Helicobacter Pylori may help treat Crohn's disease. Researchers recently reported that "after treatment [with antibiotics against H. Pylori], clinical remission [of Crohn's disease] was achieved in all patients", regardless of the type of therapy received. At the same time, H. Pylori infection was eradicated in 28 of the 30 infected patients.
"What this shows is that by eradicating H. Pylori infection... we achieved a remission of Crohn's disease," Dr. Mantzaris explained. The authors stress that their findings do not mean that H. Pylori causes Crohn's disease. But it does raise the issue of "whether regimens aimed at eradicating H. Pylori in infected patients with Crohn's disease may also achieve remission of Crohn's disease." |
| Digestion |
Gastritis
Gastric/Peptic Ulcers
Hydrochloric Acid Deficiency | Infection with H. (helicobacter) pylori can impair HCL production. Low HCL production may also contribute to an overgrowth of H. pylori. |
| Skin-Hair-Nails |
Rosacea |
| |  | |  |
Risk factors for Helicobacter Pylori Infection: | |  | | | | Infections | Dysbiosis, Bacterial | The speculation on validity of restoration of the gastric microecosystem has been demonstrated by therapeutic effects of Lactobacilli Bulgaricus (LBG) administration on H. pylori-associated diseases (invitro). But whether Lactobacilli inhibit H. pylori-LPS-induced IL-8 production through blocking H. pylori-LPS-activated TLR4 pathway hasn't been well researched. A research article published on August 28, 2008 in the World Journal of Gastroenterology addresses this question.
This evaluation of LBG as a probiotic model revealed an important and novel relationship between H. pylori-LPS-activated TLR4 signaling and selective microflora. This report adds to our understanding of the signal pathways in the gastric epithelia involved in inflammatory responses that are regulated by probiotics and pathogenic bacteria composing the gastric microecosystem. |
| Symptoms - Gas-Int - Conditions |
Probably/history of H. Pylori infection
History of gastritis
History of stomach ulcer
Counter-indicators:
History of H. Pylori infection |
| |  | |  |
Helicobacter Pylori Infection suggests the following may be present: | |  | | | | Autoimmune | Crohn's Disease | Drug therapies used to fight the ulcer-causing bacteria Helicobacter Pylori may help treat Crohn's disease. Researchers recently reported that "after treatment [with antibiotics against H. Pylori], clinical remission [of Crohn's disease] was achieved in all patients", regardless of the type of therapy received. At the same time, H. Pylori infection was eradicated in 28 of the 30 infected patients.
"What this shows is that by eradicating H. Pylori infection... we achieved a remission of Crohn's disease," Dr. Mantzaris explained. The authors stress that their findings do not mean that H. Pylori causes Crohn's disease. But it does raise the issue of "whether regimens aimed at eradicating H. Pylori in infected patients with Crohn's disease may also achieve remission of Crohn's disease." |
|
| |  | |  |
Helicobacter Pylori Infection can lead to:
Recommendations for Helicobacter Pylori Infection: | |  | | | | Animal-based | Probiotics / Fermented Foods | Supplementation for one month with Lactobacillus and Bifidobacterium yogurt after one week of triple antibiotic therapy enhanced H. Pylori eradication. Only those patients supplemented with yogurt showed restoration of Bifidobacterium in their stools compared to the levels at the beginning of the trial. [Aliment Pharmacol Ther 2002;16(9): pp.1669-1676]
Using Lactobacillus johnsonii from a fermented milk product for 4 months reduced gastric inflammation and H. pylori density and improved mucus thickness in a well-controlled study of 50 patients with gastritis and H. pylori. [Aliment Pharmacol Ther 2003;18(8): pp.805-14]
A review of thirteen human studies concluded that probiotics may have a place as prophylaxis and supportive treatment of Helicobacter pylori infections. [Int J Antimicrob Agents 2003;22(4): pp.360-6] |
Propolis / Bee Products | In a clinical trial of 45 patients with dyspepsia, the subjects were given 30ml (about 1 ounce) of raw honey three times a day. After treatment, the number of patients with blood in their stools caused by peptic ulcers decreased from 37 to 4; the number of patients with dyspepsia decreased from 41 to 8; the number with gastritis or duodenitis, as viewed by endoscope, decreased from 24 to 15; and the number with duodenal ulcers decreased from 7 to 2. In another study on gastric ulcers, the healing rate from raw honey was 70%, measured as the number of honey-treated ulcers compared to the untreated control group. A study in 1994 showed that the Manuka antibacterial factor in raw active Manuka honey completely halted the growth of Helicobacter pylori (the bacteria responsible for upper G.I. dyspepsia of stomach ulcers) at concentrations as low as 5%, but the hydrogen peroxide components in other honeys did not, even at concentrations as high as 50%. |
| Botanical |
Mastic Gum | Mastic Gum kills H. Pylori. [NEJM 1998 Dec 24;339(26):1946]
However, a 14 day trial with mastic gum (1 gm QID) had no effect on Helicobacter pylori status in a study of nine patients with H. pylori infection and no ulcers. [ J Antimicrob Chemother 2003;52(3): pp.522-3] |
Tea Tree oils (Melaleuca / Leptospermum - Manuka) | Tea tree oil, taken internally, is reported to be useful in killing H. Pylori when taken at 15 drops of 100% strength twice daily. It may need to be taken in juice in order to mask it's strong flavor and with a pinched nose to mask it's odor. |
| Diet |
Increased Water Consumption | Drinking more water alone has resolved many cases of H. Pylori infection. The suggested amount is 1 quart per 50 pounds of body weight or generally about 12 glasses per day. Most ulcers can be treated with water consumption and regular use of a good probiotic product. (Am J Gastroenterol May 1999;94: pp.1200-1202.) |
| Drug |
Antibiotics | It is not recommended to treat H Pylori with a single medication so combination therapy should always be used. There are a number of combination therapies in common use e.g. dual, triple and quadruple, but at this time the most proven effective treatment is a 2-week course of triple therapy. This involves taking two antibiotics to kill the bacteria and either an acid suppressor or stomach-lining shield. This therapy regimen reduces ulcer symptoms, kills the bacteria and prevents recurrence in more than 90% of patients.
At this time, in Austrailia, a proven and effective treatment for H. pylori is a 7-day course of medication called Triple Therapy comprising two antibiotics, amoxicillin and clarithromycin, to kill the bacteria together with an acid suppressor to enhance the antibiotic activity. This regimen of triple therapy reduces ulcer symptoms, kills H. pylori and prevents ulcer recurrence in more than 80% of patients. Antibiotic regimens recommended for patients may soon differ across regions of the world because different areas have begun to show resistance to particular antibiotics. |
| Mineral |
Bismuth | Nutrient |
Essential Fatty Acids | Essential fatty acids have the ability to inhibit the growth of Helicobacter pylori and suppress acid production. |
| Vitamins |
Vitamin C (Ascorbic Acid) | A study showed vitamin C levels to be low in atrophic gastritis and Helicobacter Pylori infection. |
Vitamin B12 (Cobalamine) | H. Pylori infection may result in Vitamin B12 deficiency. |
|
| |  | |  |
KEY |  | Weak or unproven link |  |  | Strong or generally accepted link |  |  | Proven definite or direct link |  |  | Very strongly or absolutely counter-indicative |  |  | May do some good |  |  | Likely to help |  |  | Highly recommended |
|
 |